Company performance
Add to research
Current Price
as of Mar 14, 2025$11.19
P/E Ratio
214.79
Market Cap
$2.39B
Loading...
Description
Add to research
Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network(Europe), Marketing through Own Network(United States), Marketing by Licensees, Research and Development Activity, and Corporate and Manufacturing services segments. The company was founded in 1943 and is headquartered in Barcelona, Spain.
Metrics
Add to research
Overview
- HQBarcelona, CT
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerALM
- Price$11.188705+2.76%
Trading Information
- Market cap$2.39B
- Float34.79%
- Average Daily Volume (1m)189,406
- Average Daily Volume (3m)137,256
- EPS$0.05
Company
- Revenue$985.72M
- Rev growth (1yr)10.20%
- Net income$10.15M
- Gross margin39.94%
- EBITDA margin18.72%
- EBITDA$184.55M
- EV$1.75B
- EV/Revenue1.78
- P/E214.79
- P/S2.21
- P/B1.48
- Debt/Equity26.18
Documents
Add to research
Factset Street Account
Factset